These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


198 related items for PubMed ID: 1701081

  • 1. Intratypic variation of herpes simplex virus type 2 isolates detected by monoclonal antibodies against viral glycoproteins.
    Bhattarakosol P, Yoosook C, Cross A.
    Arch Virol; 1990; 115(1-2):89-100. PubMed ID: 1701081
    [Abstract] [Full Text] [Related]

  • 2. Intratypic variations in neutralizable epitopes among herpes simplex virus type 2 isolates.
    Bhattarakosol P, Yoosook C, Matangkasombut P.
    Microbiol Immunol; 1991; 35(7):525-33. PubMed ID: 1723784
    [Abstract] [Full Text] [Related]

  • 3. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA, Marlin SD, Schwartz SA, Glorioso JC.
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [Abstract] [Full Text] [Related]

  • 4. Localization of type-specific epitopes of herpes simplex virus type 2 glycoprotein G recognized by human and mouse antibodies.
    Liljeqvist JA, Trybala E, Svennerholm B, Jeansson S, Sjögren-Jansson E, Bergström T.
    J Gen Virol; 1998 May; 79 ( Pt 5)():1215-24. PubMed ID: 9603337
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
    Ritchie MH, Oakes JE, Lausch RN.
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
    [Abstract] [Full Text] [Related]

  • 8. Cells expressing herpes simplex virus glycoprotein gC but not gB, gD, or gE are recognized by murine virus-specific cytotoxic T lymphocytes.
    Rosenthal KL, Smiley JR, South S, Johnson DC.
    J Virol; 1987 Aug; 61(8):2438-47. PubMed ID: 3037106
    [Abstract] [Full Text] [Related]

  • 9. Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans.
    Cairns TM, Huang ZY, Whitbeck JC, Ponce de Leon M, Lou H, Wald A, Krummenacher C, Eisenberg RJ, Cohen GH.
    J Virol; 2014 Nov; 88(21):12612-22. PubMed ID: 25142599
    [Abstract] [Full Text] [Related]

  • 10. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K, Tomaras GD, Jegaskanda S, Moody MA, Liao HX, Goodman KN, Berman PW, Rerks-Ngarm S, Pitisuttithum P, Nitayapan S, Kaewkungwal J, Haynes BF, Cohen JI.
    J Virol; 2017 Oct 01; 91(19):. PubMed ID: 28701403
    [Abstract] [Full Text] [Related]

  • 11. Antibody response to herpes simplex virus glycoproteins gB and gD.
    Bernstein DI, Frenkel LM, Bryson YJ, Myers MG.
    J Med Virol; 1990 Jan 01; 30(1):45-9. PubMed ID: 2154542
    [Abstract] [Full Text] [Related]

  • 12. Analogues of peptide 9-21 of glycoprotein D of herpes simplex virus and their binding to group VII monoclonal antibodies.
    Welling-Wester S, Feijlbrief M, Koedijk DG, Drijfhout JW, Weijer WJ, Scheffer AJ, Welling GW.
    Arch Virol; 1994 Jan 01; 138(3-4):331-40. PubMed ID: 7527999
    [Abstract] [Full Text] [Related]

  • 13. Epitopes of herpes simplex virus type 1 glycoprotein B that bind type-common neutralizing antibodies elicit type-specific antibody-dependent cellular cytotoxicity.
    Sanchez-Pescador L, Paz P, Navarro D, Pereira L, Kohl S.
    J Infect Dis; 1992 Sep 01; 166(3):623-7. PubMed ID: 1380051
    [Abstract] [Full Text] [Related]

  • 14. [Envelope and membrane glycoproteins of Herpes simplex virus].
    Ramos-Kuri JM.
    Rev Latinoam Microbiol; 1992 Sep 01; 34(1):23-31. PubMed ID: 1345300
    [Abstract] [Full Text] [Related]

  • 15. Mapping neuroinvasiveness of the herpes simplex virus type 1 encephalitis-inducing strain 2762 by the use of monoclonal antibodies.
    Bergström T, Sjögren-Jansson E, Jeansson S, Lycke E.
    Mol Cell Probes; 1992 Feb 01; 6(1):41-9. PubMed ID: 1312221
    [Abstract] [Full Text] [Related]

  • 16. Antigenic variants of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies.
    Holland TC, Marlin SD, Levine M, Glorioso J.
    J Virol; 1983 Feb 01; 45(2):672-82. PubMed ID: 6187935
    [Abstract] [Full Text] [Related]

  • 17. Use of monoclonal antibodies to HSV-1 and HSV-2 for serological analysis of the viral glycoproteins.
    Pereira L.
    Dev Biol Stand; 1982 Feb 01; 52():115-31. PubMed ID: 6299824
    [Abstract] [Full Text] [Related]

  • 18. Monoclonal antibodies directed against a 130K glycoprotein of bovine herpesvirus 2 cross-react with glycoprotein B of herpes simplex virus.
    Conraths FJ, Pauli G, Ludwig H.
    Virus Res; 1988 Apr 01; 10(1):53-63. PubMed ID: 2837013
    [Abstract] [Full Text] [Related]

  • 19. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge.
    Roberts PL, Duncan BE, Raybould TJ, Watson DH.
    J Gen Virol; 1985 May 01; 66 ( Pt 5)():1073-85. PubMed ID: 2582080
    [Abstract] [Full Text] [Related]

  • 20. Antiviral activities of human monoclonal antibodies to herpes simplex virus.
    Fujinaga S, Sugano T, Matsumoto Y, Masuho Y, Mori R.
    J Infect Dis; 1987 Jan 01; 155(1):45-53. PubMed ID: 3025308
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.